Manufacturing standards are considered key to preventing drug recalls and shortages.

被引：0

|

作者：

Wechsler, Jill

机构：

来源：

BIOPHARM INTERNATIONAL | 2013年 / 26卷 / 10期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：12 / 13

页数：2

相关论文

共 31 条

[1] Impact of oncology drug shortages.
Emanuel, Ezekiel J.
Shuman, Katie
Chinn, Derek
Gogineni, Keerthi
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (18)
[2] Quality manufacturing key to stemming drug shortages
1600, UBM Medica Periodical Publication (40):
[3] Quality manufacturing key to reducing drug shortages
Wechsler, Jill
Pharmaceutical Technology, 2018, 42 (12) : 14 - 15
[4] Quality Manufacturing Key to Stemming Drug Shortages
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2016, 29 (08) : 8 - 9
[5] Quality Manufacturing Key to Reducing Drug Shortages
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2018, 31 (12) : 8 - 9
[6] Modern Drug Manufacturing Key to COVID-19 Response Policy makers seek to ensure supplies of new therapies and to limit shortages.
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2020, 33 (05) : 8 - 9
[7] Drug shortages. Part 2: Trends, causes and solutions
Aronson, Jeffrey K.
Heneghan, Carl
Ferner, Robin E.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (10) : 2957 - 2963
[8] Drug shortages. Part 1. Definitions and harms
Aronson, Jeffrey K.
Heneghan, Carl
Ferner, Robin E.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (10) : 2950 - 2956
[9] Manufacturing Decline Yields Drug Shortages
Connelly, Patrick
Quinn, Brian Patrick
SCIENCE, 2011, 333 (6039) : 156 - 157
[10] Drug recalls, shortages suggest FDA needs greater authority for manufacturer compliance
Wechsler, Jill
FORMULARY, 2010, 45 (08) : 265 - 265

← 1 2 3 4 →